NCT06314022 A Mobile Application to Improve the Quality of Colonoscopy in Colorectal Cancer Screening Program (PrepColon APP)
| NCT ID | NCT06314022 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospital del Rio Hortega |
| Condition | Colorectal Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 470 participants |
| Start Date | 2024-05-02 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 470 participants in total. It began in 2024-05-02 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Colonoscopy is the gold standard for the diagnosis and resection of preneoplastic lesions, allowing the prevention of colon cancer. A colonoscopy is more efficient with proper preparation of the colon, as it allows for a higher rate of adenoma detection and cecal intubation. In routine practice, up to 30% of colonoscopies are poorly prepared and 11% of patients do not show up for their appointment. Adenomas not visualized in the initial colonoscopy due to poor preparation reached 68% and the rate of undetected cancers was 66.7%. A proper colon cleanse is conditioned by different factors; among them, failure to comply with the diet and take laxatives poses 5 times the risk of having a deficient colon preparation. The purpose of our study is the design and implementation of an app that facilitates the preparation of colonoscopy and evaluates its impact on compliance with diet and laxative intake.
Eligibility Criteria
Inclusion Criteria: * -Subjects between 50-69 years old from the CRC screening program with FIT (\>100ng/ml). * Informed consent granted in writing Exclusion Criteria: * Refusal to give informed consent. * Those who do not have a smartphone with a minimum version of the operating system (Android 4.4 or iOS 14, which cover more than 99% of the terminals in use) * Symptomatic patients * Subjects at elevated risk of CRC due to family history or inherited polyposis diseases or inflammatory bowel disease
Contact & Investigator
Henar Nuñez Rodriguez, MDPhD
PRINCIPAL INVESTIGATOR
Hospital Universitario Rio Hortega
Frequently Asked Questions
Who can join the NCT06314022 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 74 Years, studying Colorectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06314022 currently recruiting?
Yes, NCT06314022 is actively recruiting participants. Contact the research team at henarnrod@yahoo.es for enrollment information.
Where is the NCT06314022 trial being conducted?
This trial is being conducted at Valladolid, Spain, Valladolid, Spain.
Who is sponsoring the NCT06314022 clinical trial?
NCT06314022 is sponsored by Hospital del Rio Hortega. The principal investigator is Henar Nuñez Rodriguez, MDPhD at Hospital Universitario Rio Hortega. The trial plans to enroll 470 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.